Mohr Marketing Launches ‘Medical-First’ Compliance Program for Depo-Provera Meningioma Litigation
Mohr Marketing's "Medical-First" Depo-Provera program screens for confirmed meningioma diagnoses, ensuring firms receive valid, exclusive mass tort cases. ALLENTOWN, PA, UNITED STATES, February 12, 2026 /EINPresswire.com/ -- Mohr …